POSC33 Value Contribution of Filgotinib for the Treatment of Moderate to Severe Rheumatoid Arthritis Using Multi-Criteria Decision Analysis (MCDA)
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.179
https://www.valueinhealthjournal.com/article/S1098-3015(21)01974-4/fulltext
Title :
POSC33 Value Contribution of Filgotinib for the Treatment of Moderate to Severe Rheumatoid Arthritis Using Multi-Criteria Decision Analysis (MCDA)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01974-4&doi=10.1016/j.jval.2021.11.179
First page :
Section Title :
Open access? :
No
Section Order :
10946